Argonaut Technologies' Stockholders Approve Sale of Assets to Biotage
Advertisement
Argonaut Technologies announced that its stockholders have approved the sale of the assets of its chemistry consumables business and certain assets of its process chemistry business, which constitute substantially all of its assets except for its cash, to Biotage AB of Uppsala, Sweden. Argonaut and Biotage expect to close the transaction on June 3, 2005.
Most read news
Other news from the department business & finance

Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Dow Completes Expansion of METHOCEL Cellulose Ethers Plant at Stade, Germany
NuGenesis® Technologies Awarded Patent For Its NuGenesis® Scientific Data Management System (SDMS)
Friedrich_Albrecht_Carl_Gren
Songwon and HPL to form a Joint Venture for Polymer Stabilizers
Category:Synthetic_opioids
Siltstone

Bioindicator for the occurrence of PFAS - The liver of wild boar indicates the level of PFAS contamination

Consortium scales up production of bio-aromatics from waste
